Precise Transvaginal Tape Placement Trial
Primary Purpose
Stress Urinary Incontinence, Urinary Incontinence
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Foley Catheter
Sponsored by
About this trial
This is an interventional treatment trial for Stress Urinary Incontinence focused on measuring TVT, Stress urinary incontinence
Eligibility Criteria
Inclusion Criteria:
- Candidates for TVT
- >=18 years of age to participate
Exclusion Criteria:
- Inability to give informed consent
- Previous SUI(stress urinary incontinence) treatment including TVT, Burch or urethral bulking agents
- Previous bladder, urethral malignancies or vaginal/pelvic radiation treatment.
- Pregnant women cannot participate
Sites / Locations
- Loyola University Health System
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Intraop Foley catheter measurement
Without intraop Foley cath measurement
Arm Description
20 women will have intraoperative Foley catheter measurement of the urethral length
20 women without intraoperative Foley catheter measurement of the urethral length
Outcomes
Primary Outcome Measures
If using a Foley catheter is a reliable way to measure the urethral length before placing the tension free vaginal tape in the mid-urethra.
measurement of the urethral length by marking the Foley catheter at the urethral meatus when it is placed at the start of the surgical case. When the catheter is removed, the length from the end of the Foley balloon to the marking at the urethra will be measured as urethral length, the mid urethral point will then be determined by dividing the urethral length be two where the incision of sling placement will be made.
Secondary Outcome Measures
Comparing urethral length measurement with the Foley catheter and 3D ultrasound.
All women in the study will have an ultrasound at the end of their surgical procedure and a follow-up ultrasound at 2 weeks post operatively to assess for sling migration.
Location change of mid-urethral slings from the time of surgery to 2 weeks after surgery.
We will then compare the mid-point location of the midurethral sling between the group that received an intra-op Foley catheter measurement to the group that didn't receive the Foley catheter.
Stratify the data based on patient race, BMI, prolapse and age
Stratify the data based on patient race, BMI, prolapse and age
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02101489
Brief Title
Precise Transvaginal Tape Placement Trial
Official Title
Precise Transvaginal Tape Placement Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
March 2014 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
November 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Loyola University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This purpose of this study is to study is to see if intra-operative urethral length measurement with the Foley catheter will improve the placement of a synthetic sling in the mid-urethra.
Detailed Description
This study will assess the effect of intraoperative measurement of the urethral length with the Foley catheter in optimization of sling placement in the mid female urethra. Of note, the Foley catheter is well-tolerated, placed routinely during surgery to drain the bladder and has no complications associated with it. Women who have chosen to undergo trans-vaginal tape sling (TVT) for stress urinary incontinence will be asked to enroll in this randomized trial by the study team during their clinic visit. Randomization will be performed by the FPMRS study nurse coordinator after a woman has given her informed consent and meets the study criteria. Twenty women will be randomized to undergo measurement of the urethral length by marking the Foley catheter at the urethral meatus when it is placed at the start of the surgical case. When the catheter is removed, the length from the end of the Foley balloon to the marking at the urethra will be measured as urethral length, the mid urethral point will then be determined by dividing the urethral length be two where the incision of sling placement will be made and twenty women will have our usual pre-operative assessment (which does not include intraoperative measurement of the urethral length with the Foley catheter) for the treatment of symptomatic stress urinary incontinence All women participating in the study will receive an intra-operative 3-D trans-vaginal ultrasound (BK Flex Focus ultrasound with the 8838 transvaginal probe). The image will be stored and reviewed for; urethral length, urethral sphincter complex length and width. All women in the study will have an ultrasound at the end of their surgical procedure and a follow-up ultrasound at 2 weeks post operatively to assess for sling migration. Of note, transvaginal ultrasound is well-tolerated and has no complications associated with it. All ultrasound measurements will be done by a four qualified surgeons, Dr. Elizabeth Mueller Dr. Ahmed Akl, Dr. Tanaka Dune, and Dr. Susanne Taege who have been trained on ultrasound measurements. In addition, women will complete questionnaires assessing their pelvic floor symptoms pre-operatively and at 2 week following surgery. Instruments used will be the Pelvic Floor Disorders Inventory (PFDI), Medical Epidemiologic and Social Aging (MESA) and the Patient Global Impression of Improvement (PGII) [11, 12].
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress Urinary Incontinence, Urinary Incontinence
Keywords
TVT, Stress urinary incontinence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
56 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intraop Foley catheter measurement
Arm Type
Active Comparator
Arm Description
20 women will have intraoperative Foley catheter measurement of the urethral length
Arm Title
Without intraop Foley cath measurement
Arm Type
No Intervention
Arm Description
20 women without intraoperative Foley catheter measurement of the urethral length
Intervention Type
Other
Intervention Name(s)
Foley Catheter
Intervention Description
20 with intraoperative Foley catheter measurement of the urethral length and 20 without
Primary Outcome Measure Information:
Title
If using a Foley catheter is a reliable way to measure the urethral length before placing the tension free vaginal tape in the mid-urethra.
Description
measurement of the urethral length by marking the Foley catheter at the urethral meatus when it is placed at the start of the surgical case. When the catheter is removed, the length from the end of the Foley balloon to the marking at the urethra will be measured as urethral length, the mid urethral point will then be determined by dividing the urethral length be two where the incision of sling placement will be made.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Comparing urethral length measurement with the Foley catheter and 3D ultrasound.
Description
All women in the study will have an ultrasound at the end of their surgical procedure and a follow-up ultrasound at 2 weeks post operatively to assess for sling migration.
Time Frame
2 weeks
Title
Location change of mid-urethral slings from the time of surgery to 2 weeks after surgery.
Description
We will then compare the mid-point location of the midurethral sling between the group that received an intra-op Foley catheter measurement to the group that didn't receive the Foley catheter.
Time Frame
2 weeks
Title
Stratify the data based on patient race, BMI, prolapse and age
Description
Stratify the data based on patient race, BMI, prolapse and age
Time Frame
6 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Candidates for TVT
>=18 years of age to participate
Exclusion Criteria:
Inability to give informed consent
Previous SUI(stress urinary incontinence) treatment including TVT, Burch or urethral bulking agents
Previous bladder, urethral malignancies or vaginal/pelvic radiation treatment.
Pregnant women cannot participate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth R Mueller, M.D.
Organizational Affiliation
Loyola University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Loyola University Health System
City
Maywood
State/Province
Illinois
ZIP/Postal Code
60153
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
21944223
Citation
Aigmueller T, Trutnovsky G, Tamussino K, Kargl J, Wittmann A, Surtov M, Kern P, Frudinger A, Riss P, Bjelic-Radisic V. Ten-year follow-up after the tension-free vaginal tape procedure. Am J Obstet Gynecol. 2011 Nov;205(5):496.e1-5. doi: 10.1016/j.ajog.2011.07.010. Epub 2011 Jul 20.
Results Reference
background
PubMed Identifier
20069417
Citation
Olsson I, Abrahamsson AK, Kroon UB. Long-term efficacy of the tension-free vaginal tape procedure for the treatment of urinary incontinence: a retrospective follow-up 11.5 years post-operatively. Int Urogynecol J. 2010 Jun;21(6):679-83. doi: 10.1007/s00192-009-1083-7. Epub 2010 Jan 13.
Results Reference
background
PubMed Identifier
18535753
Citation
Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1043-7. doi: 10.1007/s00192-008-0666-z. Epub 2008 Jun 6.
Results Reference
background
PubMed Identifier
23563892
Citation
Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013 Aug;24(8):1265-9. doi: 10.1007/s00192-013-2090-2. Epub 2013 Apr 6.
Results Reference
background
PubMed Identifier
17132481
Citation
Bjelic-Radisic V, Dorfer M, Greimel E, Frudinger A, Tamussino K, Winter R. Quality of life and continence 1 year after the tension-free vaginal tape operation. Am J Obstet Gynecol. 2006 Dec;195(6):1784-8. doi: 10.1016/j.ajog.2006.07.014.
Results Reference
background
PubMed Identifier
18288705
Citation
Kociszewski J, Rautenberg O, Perucchini D, Eberhard J, Geissbuhler V, Hilgers R, Viereck V. Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourol Urodyn. 2008;27(6):485-90. doi: 10.1002/nau.20556.
Results Reference
background
PubMed Identifier
17132484
Citation
Rahn DD, Marinis SI, Schaffer JI, Corton MM. Anatomical path of the tension-free vaginal tape: reassessing current teachings. Am J Obstet Gynecol. 2006 Dec;195(6):1809-13. doi: 10.1016/j.ajog.2006.07.009.
Results Reference
background
PubMed Identifier
11905885
Citation
McGuire EJ, Lytton B. Pubovaginal sling procedure for stress incontinence. 1978. J Urol. 2002 Feb;167(2 Pt 2):1120-3; discussion 1124. doi: 10.1016/s0022-5347(02)80355-x. No abstract available.
Results Reference
background
PubMed Identifier
21344495
Citation
Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, Nygaard I, Weidner A, Janz NK, Spino C. Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn. 2011 Apr;30(4):541-6. doi: 10.1002/nau.20934. Epub 2011 Feb 22.
Results Reference
background
Learn more about this trial
Precise Transvaginal Tape Placement Trial
We'll reach out to this number within 24 hrs